Cargando…
Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial
The activity and mild toxicity profile of single-agent gemcitabine therapy in untreated (chemonaive) patients with non-small-cell lung cancer (NSCLC) is well documented. This phase II trial was conducted to determine the objective tumour response rate and toxicity profile of single-agent gemcitabine...
Autores principales: | Kooten, M Van, Traine, G, Cinat, G, Cazap, E, Comba, A Zori, Vicente, H, Sena, S, Nievas, O Rodriguez, Orlando, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374290/ https://www.ncbi.nlm.nih.gov/pubmed/10555756 http://dx.doi.org/10.1038/sj.bjc.6690774 |
Ejemplares similares
-
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
por: Douillard, J Y, et al.
Publicado: (2001) -
BRAZILIAN AND ARGENTINEAN MULTICENTRIC STUDY IN THE SURGICAL
MINIMALLY INVASIVE TREATMENT OF PILONIDAL CYST
por: MENDES, Carlos Ramon Silveira, et al.
Publicado: (2019) -
Prospection and Evaluation of (Hemi) Cellulolytic Enzymes Using Untreated and Pretreated Biomasses in Two Argentinean Native Termites
por: Ben Guerrero, Emiliano, et al.
Publicado: (2015) -
Genomic continuity of Argentinean Mennonites
por: Pardo-Seco, Jacobo, et al.
Publicado: (2016) -
Anti-Trypanosoma cruzi Activity of Extracts from Argentinean Asteraceae Species
por: Selener, Mariana G., et al.
Publicado: (2019)